Potential, limitations and risks of cannabis-derived products in cancer treatment

HJ Woerdenbag, P Olinga, EA Kok, DAP Brugman… - Cancers, 2023 - mdpi.com
Simple Summary It is easy to find success stories on the internet of patients with cancer who
seem to benefit from using cannabis products. However, scientific substantiation is usually …

US trends in registration for medical cannabis and reasons for use from 2016 to 2020: an observational study

KF Boehnke, O Dean, RL Haffajee… - Annals of internal …, 2022 - acpjournals.org
Background: Cannabis policy liberalization has increased cannabis availability for medical
or recreational purposes. Up-to-date trends in medical cannabis licensure can inform clinical …

Trends in US medical cannabis registrations, authorizing clinicians, and reasons for use from 2020 to 2022

KF Boehnke, R Sinclair, F Gordon… - Annals of internal …, 2024 - acpjournals.org
Background: As medical cannabis availability increases, up-to-date trends in medical
cannabis licensure can inform clinical policy and care. Objective: To describe current trends …

The state of the evidence on the association between state cannabis laws and opioid-related outcomes: a review

KN Tormohlen, MC Bicket, S White, CL Barry… - Current addiction …, 2021 - Springer
Abstract Purpose of Review This review summarizes studies examining impacts of medical
and recreational cannabis laws on opioid prescribing, opioid use, opioid use disorder …

Analysis of state cannabis laws and dispensary staff recommendations to adults purchasing medical cannabis

JS Merlin, A Althouse, R Feldman, JH Arnsten… - JAMA Network …, 2021 - jamanetwork.com
Importance Over the last decade, cannabis has become more accessible through the
proliferation of dispensaries in states that have legalized its use. Most patients using …

[HTML][HTML] Applying lessons from Cannabis to the psychedelic highway: Buckle up and build infrastructure

KF Boehnke, AK Davis, J McAfee - JAMA Health Forum, 2022 - jamanetwork.com
In 2020, Oregon became the first state in the US to decriminalize use of many illicit
substances, including mushrooms containing psilocybin, and allow adults aged 21 years …

The cannabis policy scale: a new research and surveillance tool for US states

JG Blanchette, RL Pacula, R Smart, MC Lira… - Journal of studies on …, 2022 - jsad.com
Objective: Rapid shifts toward cannabis liberalization in the United States have created
immense policy variability that is challenging to measure. We developed composite …

Cannabis use among cancer survivors in 22 states: Results from the Behavioral Risk Factor Surveillance System, 2020

AE Sedani, JE Campbell, LA Beebe - Cancer, 2023 - Wiley Online Library
Background This study identified factors associated with recent cannabis use and cannabis
use for medical purposes among cancer survivors relative to individuals without a history of …

Rating the comparative efficacy of state-level cannabis policies on recreational cannabis markets in the United States

JG Blanchette, RL Pacula, R Smart, MC Lira… - International Journal of …, 2022 - Elsevier
Background Cannabis policy is develo** faster than empirical evidence about policy
effects. With a panel of experts in substance use policy development and research, we …

[HTML][HTML] Medical cannabis identity and public health paternalism

A Reiman, JS Meisel, R Capler, DP McCready - Public Health in Practice, 2023 - Elsevier
Objectives State-dependent and variable lists of medical conditions granting access to
medical cannabis in the United States may be an example of public health paternalism …